Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis - PubMed
. 2007 Dec;293(6):G1147-54.
doi: 10.1152/ajpgi.00032.2007. Epub 2007 Oct 11.
Affiliations
- PMID: 17932231
- DOI: 10.1152/ajpgi.00032.2007
Free article
Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis
Penelope C Georges et al. Am J Physiol Gastrointest Liver Physiol. 2007 Dec.
Free article
Abstract
Liver fibrosis, the response to chronic liver injury, results from the activation of mesenchymal cells to fibrogenic myofibroblasts. We have recently shown that two key myofibroblast precursor populations, hepatic stellate cells and portal fibroblasts, undergo activation in culture in response to increasing substrate stiffness. We therefore hypothesized that alterations in liver stiffness precede myofibroblast activation and fibrosis in vivo as well. To test this hypothesis, we induced fibrosis in rats by twice weekly injections of carbon tetrachloride (CCl(4)) and then killed the animals at various time points ranging from 3 to 70 days after the initiation of injury. The shear storage modulus of the whole liver was measured on fresh tissue; fixed and frozen tissue from the same livers was used to quantify fibrosis. We observed that liver stiffness increased immediately and continued to increase, leveling out by day 28. Fibrosis, measured histologically by trichrome staining as well as by quantitative sirius red staining, increased with time, although these increases were delayed relative to changes in stiffness. There was no direct correlation between stiffness and fibrosis at early or late time points. Treatment of a second cohort of rats with the lysyl oxidase inhibitor, beta-aminopropionitrile (BAPN), partially prevented early increases in liver stiffness. We concluded that increases in liver stiffness precede fibrosis and potentially myofibroblast activation. Liver stiffness appears to result from matrix cross-linking and possibly other unknown variables in addition to matrix quantity. We suggest that increased liver stiffness may play an important role in initiating the early stages of fibrosis.
Similar articles
-
Perepelyuk M, Terajima M, Wang AY, Georges PC, Janmey PA, Yamauchi M, Wells RG. Perepelyuk M, et al. Am J Physiol Gastrointest Liver Physiol. 2013 Mar 15;304(6):G605-14. doi: 10.1152/ajpgi.00222.2012. Epub 2013 Jan 17. Am J Physiol Gastrointest Liver Physiol. 2013. PMID: 23328207 Free PMC article.
-
Zhang F, Ma J, Lu Y, Ni GX, Ni CY, Zhang XJ, Wang AY, Zheng SZ. Zhang F, et al. Zhen Ci Yan Jiu. 2012 Feb;37(1):8-14. Zhen Ci Yan Jiu. 2012. PMID: 22574562 Chinese.
-
Liu SB, Ikenaga N, Peng ZW, Sverdlov DY, Greenstein A, Smith V, Schuppan D, Popov Y. Liu SB, et al. FASEB J. 2016 Apr;30(4):1599-609. doi: 10.1096/fj.14-268425. Epub 2015 Dec 23. FASEB J. 2016. PMID: 26700732
-
The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis.
Wells RG. Wells RG. J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S158-61. doi: 10.1097/01.mcg.0000155516.02468.0f. J Clin Gastroenterol. 2005. PMID: 15758652 Review.
-
Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmoulière A. Guyot C, et al. Int J Biochem Cell Biol. 2006 Feb;38(2):135-51. doi: 10.1016/j.biocel.2005.08.021. Epub 2005 Sep 23. Int J Biochem Cell Biol. 2006. PMID: 16257564 Review.
Cited by
-
He ZQ, Yuan XW, Lu ZB, Li YH, Li YF, Liu X, Wang L, Zhang Y, Zhou Q, Li W. He ZQ, et al. Fundam Res. 2021 Dec 23;2(1):37-47. doi: 10.1016/j.fmre.2021.11.033. eCollection 2022 Jan. Fundam Res. 2021. PMID: 38933917 Free PMC article.
-
Umehara T, Urabe N, Obata T, Yamaguchi T, Tanaka A, Shimada M. Umehara T, et al. Reprod Med Biol. 2020 Aug 26;19(4):415-424. doi: 10.1002/rmb2.12345. eCollection 2020 Oct. Reprod Med Biol. 2020. PMID: 33071644 Free PMC article.
-
Relationship of and cross-talk between physical and biologic properties of the glomerulus.
Miller RT, Janmey PA. Miller RT, et al. Curr Opin Nephrol Hypertens. 2015 Jul;24(4):393-400. doi: 10.1097/MNH.0000000000000138. Curr Opin Nephrol Hypertens. 2015. PMID: 26050128 Free PMC article. Review.
-
Caliari SR, Perepelyuk M, Soulas EM, Lee GY, Wells RG, Burdick JA. Caliari SR, et al. Integr Biol (Camb). 2016 Jun 13;8(6):720-8. doi: 10.1039/c6ib00027d. Epub 2016 May 10. Integr Biol (Camb). 2016. PMID: 27162057 Free PMC article.
-
Understanding nanoparticle-liver interactions in nanomedicine.
He Y, Wang Y, Wang L, Jiang W, Wilhelm S. He Y, et al. Expert Opin Drug Deliv. 2024 Jun;21(6):829-843. doi: 10.1080/17425247.2024.2375400. Epub 2024 Jul 4. Expert Opin Drug Deliv. 2024. PMID: 38946471 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical